Simulations Plus Inc
NASDAQ:SLP

Watchlist Manager
Simulations Plus Inc Logo
Simulations Plus Inc
NASDAQ:SLP
Watchlist
Price: 31.32 USD 4.26% Market Closed
Market Cap: 628.6m USD
Have any thoughts about
Simulations Plus Inc?
Write Note

Net Margin
Simulations Plus Inc

14.2%
Current
19%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
14.2%
=
Net Income
10m
/
Revenue
70m

Net Margin Across Competitors

Country US
Market Cap 628m USD
Net Margin
14%
Country US
Market Cap 35B USD
Net Margin
24%
Country US
Market Cap 31.3B USD
Net Margin
10%
Country AU
Market Cap 23.2B AUD
Net Margin
50%
Country US
Market Cap 9B USD
Net Margin
34%
Country JP
Market Cap 967.6B JPY
Net Margin
16%
Country US
Market Cap 5.7B USD
Net Margin
4%
Country US
Market Cap 5.4B USD
Net Margin
-6%
Country SE
Market Cap 53.1B SEK
Net Margin
25%
Country US
Market Cap 2.4B EUR
Net Margin
-4%
Country CN
Market Cap 16.4B CNY
Net Margin
11%
No Stocks Found

Simulations Plus Inc
Glance View

Market Cap
628m USD
Industry
Health Care

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.

SLP Intrinsic Value
20.55 USD
Overvaluation 34%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
14.2%
=
Net Income
10m
/
Revenue
70m
What is the Net Margin of Simulations Plus Inc?

Based on Simulations Plus Inc's most recent financial statements, the company has Net Margin of 14.2%.